메뉴 건너뛰기




Volumn 2014, Issue 1, 2014, Pages 444-449

Thrombotic microangiopathy and indications for therapeutic plasma exchange

Author keywords

[No Author keywords available]

Indexed keywords

APHERESIS; HUMAN; MEDICAL SOCIETY; PLASMAPHERESIS; PRACTICE GUIDELINE; THROMBOTIC MICROANGIOPATHIES;

EID: 84930634014     PISSN: 15204391     EISSN: 15204383     Source Type: Journal    
DOI: 10.1182/asheducation-2014.1.444     Document Type: Article
Times cited : (31)

References (38)
  • 1
    • 84862070781 scopus 로고    scopus 로고
    • Endothelial cells and thrombotic microangiopathy
    • Motto D. Endothelial cells and thrombotic microangiopathy. Semin Nephrol. 2012;32(2):208-214.
    • (2012) Semin Nephrol , vol.32 , Issue.2 , pp. 208-214
    • Motto, D.1
  • 2
    • 84863841323 scopus 로고    scopus 로고
    • Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies
    • Scully M, Hunt BJ, Benjamin S, et al. Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br J Haematol. 2012;158(3):323-335.
    • (2012) Br J Haematol , vol.158 , Issue.3 , pp. 323-335
    • Scully, M.1    Hunt, B.J.2    Benjamin, S.3
  • 3
    • 84874193062 scopus 로고    scopus 로고
    • Evaluation of patients with microangiopathic hemolytic anemia and thrombocytopenia
    • George JN and Charania RS. Evaluation of patients with microangiopathic hemolytic anemia and thrombocytopenia. Semin Thromb Hemost. 2013;39(2):153-160.
    • (2013) Semin Thromb Hemost , vol.39 , Issue.2 , pp. 153-160
    • George, J.N.1    Charania, R.S.2
  • 5
    • 84886405720 scopus 로고    scopus 로고
    • Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP)
    • Shah N, Rutherford C, Matevosyan K, Shen YM, Sarode R. Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP). Br J Haematol. 2013;163(4):514-519.
    • (2013) Br J Haematol , vol.163 , Issue.4 , pp. 514-519
    • Shah, N.1    Rutherford, C.2    Matevosyan, K.3    Shen, Y.M.4    Sarode, R.5
  • 6
    • 84881381644 scopus 로고    scopus 로고
    • Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: The sixth special issue
    • Schwartz J, Winters JL, Padmanabhan A, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue. J Clin Apher. 2013;28(3):145-284.
    • (2013) J Clin Apher , vol.28 , Issue.3 , pp. 145-284
    • Schwartz, J.1    Winters, J.L.2    Padmanabhan, A.3
  • 7
    • 25144446865 scopus 로고    scopus 로고
    • The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: All patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency
    • Terrell DR, Williams LA, Vesely SK, Lammle B, Hovinga JA, George JN. The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency. J Thromb Haemost. 2005;3(7):1432-1436.
    • (2005) J Thromb Haemost , vol.3 , Issue.7 , pp. 1432-1436
    • Terrell, D.R.1    Williams, L.A.2    Vesely, S.K.3    Lammle, B.4    Hovinga, J.A.5    George, J.N.6
  • 8
    • 0026048114 scopus 로고
    • Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura
    • Rock GA, Shumak KH, Buskard NA, et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med. 1991;325(6):393-397.
    • (1991) Canadian Apheresis Study Group. N Engl J Med , vol.325 , Issue.6 , pp. 393-397
    • Rock, G.A.1    Shumak, K.H.2    Buskard, N.A.3
  • 9
    • 84862783878 scopus 로고    scopus 로고
    • The use of ADAMTS13 activity, platelet count, and serum creatinine to differentiate acquired thrombotic thrombocytopenic purpura from other thrombotic microangiopathies
    • Cataland SR, Yang S, Wu HM. The use of ADAMTS13 activity, platelet count, and serum creatinine to differentiate acquired thrombotic thrombocytopenic purpura from other thrombotic microangiopathies. Br J Haematol. 2012;157(4):501-503.
    • (2012) Br J Haematol , vol.157 , Issue.4 , pp. 501-503
    • Cataland, S.R.1    Yang, S.2    Wu, H.M.3
  • 10
    • 0032569884 scopus 로고    scopus 로고
    • Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolyticuremic syndrome
    • Furlan M, Robles R, Galbusera M, et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolyticuremic syndrome. N Engl J Med. 1998;339(22):1578-1584.
    • (1998) N Engl J Med , vol.339 , Issue.22 , pp. 1578-1584
    • Furlan, M.1    Robles, R.2    Galbusera, M.3
  • 11
    • 0032569840 scopus 로고    scopus 로고
    • Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura
    • Tsai HM and Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med. 1998;339(22):1585-1594.
    • (1998) N Engl J Med , vol.339 , Issue.22 , pp. 1585-1594
    • Tsai, H.M.1    Lian, E.C.2
  • 12
    • 0035807348 scopus 로고    scopus 로고
    • Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura
    • Levy GG, Nichols WC, Lian EC, et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature. 2001;413(6855):488-494.
    • (2001) Nature , vol.413 , Issue.6855 , pp. 488-494
    • Levy, G.G.1    Nichols, W.C.2    Lian, E.C.3
  • 13
    • 84856998772 scopus 로고    scopus 로고
    • Thrombotic microangiopathies, thrombotic thrombocytopenic purpura, and ADAMTS-13
    • Chapman K, Seldon M, Richards R. Thrombotic microangiopathies, thrombotic thrombocytopenic purpura, and ADAMTS-13. Semin Thromb Hemost. 2012;38(1):47-54.
    • (2012) Semin Thromb Hemost , vol.38 , Issue.1 , pp. 47-54
    • Chapman, K.1    Seldon, M.2    Richards, R.3
  • 14
    • 61849116707 scopus 로고    scopus 로고
    • Integrin alpha(v)beta(3) on human endothelial cells binds von Willebrand factor strings under fluid shear stress
    • Huang J, Roth R, Heuser JE, Sadler JE. Integrin alpha(v)beta(3) on human endothelial cells binds von Willebrand factor strings under fluid shear stress. Blood. 2009;113(7):1589-1597.
    • (2009) Blood , vol.113 , Issue.7 , pp. 1589-1597
    • Huang, J.1    Roth, R.2    Heuser, J.E.3    Sadler, J.E.4
  • 15
    • 2542490269 scopus 로고    scopus 로고
    • Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura
    • Zheng XL, Kaufman RM, Goodnough LT, Sadler JE. Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura. Blood. 2004;103(11):4043-4049.
    • (2004) Blood , vol.103 , Issue.11 , pp. 4043-4049
    • Zheng, X.L.1    Kaufman, R.M.2    Goodnough, L.T.3    Sadler, J.E.4
  • 16
    • 0037968640 scopus 로고    scopus 로고
    • ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: Relation to presenting features and clinical outcomes in a prospective cohort of 142 patients
    • Vesely SK, George JN, Lammle B, et al. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood. 2003;102(1):60-68.
    • (2003) Blood , vol.102 , Issue.1 , pp. 60-68
    • Vesely, S.K.1    George, J.N.2    Lammle, B.3
  • 17
    • 84870902189 scopus 로고    scopus 로고
    • Ten patient stories illustrating the extraordinarily diverse clinical features of patients with thrombotic thrombocytopenic purpura and severe ADAMTS13 deficiency
    • George JN, Chen Q, Deford CC, Al-Nouri Z. Ten patient stories illustrating the extraordinarily diverse clinical features of patients with thrombotic thrombocytopenic purpura and severe ADAMTS13 deficiency. J Clin Apher. 2012;27(6):302-311.
    • (2012) J Clin Apher , vol.27 , Issue.6 , pp. 302-311
    • George, J.N.1    Chen, Q.2    Deford, C.C.3    Al-Nouri, Z.4
  • 18
    • 34147136218 scopus 로고    scopus 로고
    • Hyperbilirubinemia interferes with ADAMTS-13 activity measurement by FRETSVWF73 assay: Diagnostic relevance in patients suffering from acute thrombotic microangiopathies
    • Meyer SC, Sulzer I, Lammle B, Kremer Hovinga JA. Hyperbilirubinemia interferes with ADAMTS-13 activity measurement by FRETSVWF73 assay: diagnostic relevance in patients suffering from acute thrombotic microangiopathies. J Thromb Haemost. 2007;5(4):866-867.
    • (2007) J Thromb Haemost , vol.5 , Issue.4 , pp. 866-867
    • Meyer, S.C.1    Sulzer, I.2    Lammle, B.3    Kremer Hovinga, J.A.4
  • 19
    • 84904095940 scopus 로고    scopus 로고
    • Congenital and acquired thrombotic thrombocytopenic purpura and pregnancy: Presentation, management and outcome of subsequent pregnancies
    • Scully M, Thomas M, Underwood M, et al. Congenital and acquired thrombotic thrombocytopenic purpura and pregnancy: presentation, management and outcome of subsequent pregnancies. Blood. 2014;124(2):211-219.
    • (2014) Blood , vol.124 , Issue.2 , pp. 211-219
    • Scully, M.1    Thomas, M.2    Underwood, M.3
  • 21
    • 84864876679 scopus 로고    scopus 로고
    • Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: Case-control study
    • Menne J, Nitschke M, Stingele R, et al. Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study. BMJ. 2012;345:e4565.
    • (2012) BMJ , vol.345 , pp. e4565
    • Menne, J.1    Nitschke, M.2    Stingele, R.3
  • 23
    • 0036331717 scopus 로고    scopus 로고
    • Invasive pneumococcal disease and hemolytic uremic syndrome
    • Brandt J, Wong C, Mihm S, et al. Invasive pneumococcal disease and hemolytic uremic syndrome. Pediatrics. 2002;110(2 Pt 1):371-376.
    • (2002) Pediatrics , vol.110 , Issue.2 , pp. 371-376
    • Brandt, J.1    Wong, C.2    Mihm, S.3
  • 24
    • 84886030991 scopus 로고    scopus 로고
    • Identification of TLR4 as the receptor that recognizes Shiga toxins in human neutrophils
    • Brigotti M, Carnicelli D, Arfilli V, et al. Identification of TLR4 as the receptor that recognizes Shiga toxins in human neutrophils. J Immunol. 2013;191(9):4748-4758.
    • (2013) J Immunol , vol.191 , Issue.9 , pp. 4748-4758
    • Brigotti, M.1    Carnicelli, D.2    Arfilli, V.3
  • 25
    • 1542330038 scopus 로고    scopus 로고
    • Pneumococcusinduced T-antigen activation in hemolytic uremic syndrome and anemia
    • Cochran JB, Panzarino VM, Maes LY, Tecklenburg FW. Pneumococcusinduced T-antigen activation in hemolytic uremic syndrome and anemia. Pediatr Nephrol. 2004;19(3):317-321.
    • (2004) Pediatr Nephrol , vol.19 , Issue.3 , pp. 317-321
    • Cochran, J.B.1    Panzarino, V.M.2    Maes, L.Y.3    Tecklenburg, F.W.4
  • 26
    • 0025359141 scopus 로고
    • Escherichia coli O157:H7 and the hemolytic uremic syndrome: Importance of early cultures in establishing the etiology
    • Tarr PI, Neill MA, Clausen CR, Watkins SL, Christie DL, Hickman RO. Escherichia coli O157:H7 and the hemolytic uremic syndrome: importance of early cultures in establishing the etiology. J Infect Dis. 1990;162(2):553-556.
    • (1990) J Infect Dis , vol.162 , Issue.2 , pp. 553-556
    • Tarr, P.I.1    Neill, M.A.2    Clausen, C.R.3    Watkins, S.L.4    Christie, D.L.5    Hickman, R.O.6
  • 27
    • 0034972253 scopus 로고    scopus 로고
    • Von Willebrand factor-cleaving protease in childhood diarrhoea-associated haemolytic uraemic syndrome
    • Hunt BJ, Lammle B, Nevard CH, Haycock GB, Furlan M. von Willebrand factor-cleaving protease in childhood diarrhoea-associated haemolytic uraemic syndrome. Thromb Haemost. 2001;85(6):975-978.
    • (2001) Thromb Haemost , vol.85 , Issue.6 , pp. 975-978
    • Hunt, B.J.1    Lammle, B.2    Nevard, C.H.3    Haycock, G.B.4    Furlan, M.5
  • 28
    • 84879402878 scopus 로고    scopus 로고
    • Role of ADAMTS13 in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura
    • Kremer Hovinga JA and Lammle B. Role of ADAMTS13 in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura. Hematology Am Soc Hematol Educ Program. 2012;2012:610-616.
    • (2012) Hematology Am Soc Hematol Educ Program , vol.2012 , pp. 610-616
    • Kremer Hovinga, J.A.1    Lammle, B.2
  • 29
    • 84867993202 scopus 로고    scopus 로고
    • Renal and neurological involvement in typical Shiga toxin-associated HUS
    • Trachtman H, Austin C, Lewinski M, Stahl RA. Renal and neurological involvement in typical Shiga toxin-associated HUS. Nat Rev Nephrol. 2012;8(11):658-669.
    • (2012) Nat Rev Nephrol , vol.8 , Issue.11 , pp. 658-669
    • Trachtman, H.1    Austin, C.2    Lewinski, M.3    Stahl, R.A.4
  • 30
    • 77958587405 scopus 로고    scopus 로고
    • Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype
    • Noris M, Caprioli J, Bresin E, et al. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol. 2010;5(10):1844-1859.
    • (2010) Clin J Am Soc Nephrol , vol.5 , Issue.10 , pp. 1844-1859
    • Noris, M.1    Caprioli, J.2    Bresin, E.3
  • 31
    • 75749153964 scopus 로고    scopus 로고
    • Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome
    • Bienaime F, Dragon-Durey MA, Regnier CH, et al. Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome. Kidney Int. 2010;77(4):339-349.
    • (2010) Kidney Int , vol.77 , Issue.4 , pp. 339-349
    • Bienaime, F.1    Dragon-Durey, M.A.2    Regnier, C.H.3
  • 32
    • 54049137505 scopus 로고    scopus 로고
    • Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome
    • Fremeaux-Bacchi V, Miller EC, Liszewski MK, et al. Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome. Blood. 2008;112(13):4948-4952.
    • (2008) Blood , vol.112 , Issue.13 , pp. 4948-4952
    • Fremeaux-Bacchi, V.1    Miller, E.C.2    Liszewski, M.K.3
  • 33
    • 79953691827 scopus 로고    scopus 로고
    • Mutations in complement regulatory proteins predispose to preeclampsia: A genetic analysis of the PROMISSE cohort
    • Salmon JE, Heuser C, Triebwasser M, et al. Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort. PLoS Med. 2011;8(3):e1001013.
    • (2011) PLoS Med , vol.8 , Issue.3 , pp. e1001013
    • Salmon, J.E.1    Heuser, C.2    Triebwasser, M.3
  • 34
    • 84884526601 scopus 로고    scopus 로고
    • The role of complement in Streptococcus pneumoniae-associated haemolytic uraemic syndrome
    • Szilagyi A, Kiss N, Bereczki C, et al. The role of complement in Streptococcus pneumoniae-associated haemolytic uraemic syndrome. Nephrol Dial Transplant. 2013;28(9):2237-2245.
    • (2013) Nephrol Dial Transplant , vol.28 , Issue.9 , pp. 2237-2245
    • Szilagyi, A.1    Kiss, N.2    Bereczki, C.3
  • 35
    • 84885717017 scopus 로고    scopus 로고
    • Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy
    • Jodele S, Licht C, Goebel J, et al. Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy. Blood. 2013;122(12): 2003-2007.
    • (2013) Blood , vol.122 , Issue.12 , pp. 2003-2007
    • Jodele, S.1    Licht, C.2    Goebel, J.3
  • 36
    • 34548313714 scopus 로고    scopus 로고
    • Screening for complement system abnormalities in patients with atypical hemolytic uremic syndrome
    • Kavanagh D, Richards A, Fremeaux-Bacchi V, et al. Screening for complement system abnormalities in patients with atypical hemolytic uremic syndrome. Clin J Am Soc Nephrol. 2007;2(3):591-596.
    • (2007) Clin J Am Soc Nephrol , vol.2 , Issue.3 , pp. 591-596
    • Kavanagh, D.1    Richards, A.2    Fremeaux-Bacchi, V.3
  • 37
    • 84902589905 scopus 로고    scopus 로고
    • Biomarkers of the alternative pathway and terminal complement activity at presentation confirms the clinical diagnosis of aHUS and differentiates aHUS from TTP
    • Cataland SR, Holers VM, Geyer S, Yang S, Wu HM. Biomarkers of the alternative pathway and terminal complement activity at presentation confirms the clinical diagnosis of aHUS and differentiates aHUS from TTP. Blood. 2014;123(24):3733-3738.
    • (2014) Blood , vol.123 , Issue.24 , pp. 3733-3738
    • Cataland, S.R.1    Holers, V.M.2    Geyer, S.3    Yang, S.4    Wu, H.M.5
  • 38
    • 84867993256 scopus 로고    scopus 로고
    • Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies
    • French Study Group for aHUS/C3G
    • Zuber J, Fakhouri F, Roumenina LT, Loirat C, Fremeaux-Bacchi V, French Study Group for aHUS/C3G. Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies. Nat Rev Nephrol. 2012;8(11):643-657.
    • (2012) Nat Rev Nephrol , vol.8 , Issue.11 , pp. 643-657
    • Zuber, J.1    Fakhouri, F.2    Roumenina, L.T.3    Loirat, C.4    Fremeaux-Bacchi, V.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.